Nabiximols (USAN), [2] sold under the brand name Sativex, is a specific Cannabis extract that was approved in 2010 as a botanical drug in the United Kingdom.

Sativex is the brand name for a cannabis-based drug called nabiximols. It’s the only drug in the UK with a licence to treat muscle stiffness and spasms (spasticity) caused by MS.

Jun 15, 2022 · Nabiximols is an oral spray containing two of the main compounds found in the cannabis plant that is approved in some countries for easing spasticity in people with multiple …

Our systematic review and meta-analysis assessed whether add-on nabiximols, can improve MS-associated refractory spasticity. The systematic literature search was performed in Web of …

Nabiximols is defined as a cannabinoid-based medication that consists of a 1:1 combination of THC and CBD, approved for treating spasticity symptoms in adults with multiple sclerosis, and …

nabiximols An herbal preparation containing a defined quantity of specific cannabinoids formulated for oromucosal spray administration with potential analgesic activity.

Jul 2, 2021 · Nabiximols is a whole-plant prescription cannabinoid approved in many regions of the world. It meets the same regulatory requirements of other pharmaceutical products in …